Member Info for syntaxity

Either artificial...or somebody somewhere knows something about the coming 18th prelims.

well to be fair, TPK did look like it was trending down. hence, i bought and sold quickly on the last bounce. a bit risky too with FTSE reaching such heights. nevertheless, i'm actually watching JUP now. always on a lookout for good entry points for a pool of stocks i trade. :) currently not in TPK but i think it will either bounce off 1600p or 1570p.

bought a couple of these at 183p. let's see where it goes in the coming weeks. great yield too.

to buy again or not to buy?

if anybody ever wondered on how are sales revenue numbers doing after the biotech selloff a few weeks ago, it is great! these are the top 2 holdings in IBT's portfolio :- http://blogs.barrons.com/stockstowatchtoday/2014/05/09/gilead-sciences-sovaldi-still-selling-biogens-tecfidera-launch-going-well/ IBT's portfolio :- http://www.investegate.co.uk/intnl--biotechnology--ibt-/rns/portfolio-update/201404141450417900E/

there seems to be renewed interest today...? anyway, IBT has been holding well at this level so I decided to top up again this morning. results from the sale of sovaldi also beat analyst estimations by almost 3 times(yes, that's 300%). and they have just started selling it in the european markets too. some hype Gilead Sciences as an "Apple in the making" hahaha. anyway, my confidence for IBT in the long run has returned.

http://www.rttnews.com/2304718/international-biotechnology-trust-hy-profit-rises-quick-facts.aspx?type=corp&SimRec=1

cheers mate. well we're not theonly ones feeling the pain...oddly enough, the share price started tanking after a bunch of director buys! http://www.investegate.co.uk/intnl--biotechnology--ibt-/rns/director-pdmr-shareholding/201402281540472616B/ my buy order towards closing didn't get triggered...but i plan to buy another batch after seeing today's closing price. perhaps tomorrow or friday.

on the 20th of march the share price was 320p. today, at 248p, it has tanked > 20% in 3 weeks. if IBT isn't going to help me grow my cash, i'd rather cut my losses and place it into other shares that are trending up. also makes me wonder, why has management not released a statement? just look at the chart! i'm still holding but if there is another annihilation today, i'm out. even though this is now 30% undervalued as it stands and even though it will be a loss for me. but if IBT stabilises, i may top up! haha thanks for your advice, know/hope u mean well.

up more than 10% in 3 days, lost half of that in 2 days. i was contemplating to hold onto this due to the great entry price i had but in the end, i sold out yesterday because other shares are not performing well and wanted to lock in some profits. until closer to the ex-div date, i'll look into ICP again. good luck, guys.

well yeah but where is the bottom? there is a 35% upside now, valuation as recent as yesterday, as per below. at IBT's current share price, it has wiped out all my profit from another share. the half year results are coming soon. wondering whether to hold on for that or just bail out. to the market maker, if you are reading this, you sure have one sick way of giving people sleepless nights.

as of yesterday, the NAV of IBT is still 331p per share. http://www.londonstockexchange.com/exchange/news/market-news/market-news-detail.html?announcementId=11916716 if you buy a few at 260p today, that's a whopping 27% discount.

what's going on here? from 380p to 260p in less than 40 days. even the top 4 holdings in IBT's portfolio hasn't dropped that much. Biogen 7.2% Gilead 6.9% Regeneron 5.9% Celgene 5.6% IBT has dropped 30% from peak at the end of february while the rest has only devalued by 20% or less.

good on ya mate. looks like we both got it right on time. not sure why but i can only suspect there is a large institutional order to fill.

appears to be holding up for a while now. perhaps consolidating to prepare for the next step up?

alright mate u look like u're having fun talking to yourself. oh yeah? really! well, toppa the day to ya. i'm off to the exchange to buy me some GSK shares. righty ho!

http://www.rttnews.com/2263386/gilead-profit-tops-estimates.aspx

http://seekingalpha.com/news/1654523-sovaldi-uptake-strong-despite-pricing-controversy

broke past previous resistance. this is heading closer to 500p.

looks like a buying opportunity coming up in time to come. target entry price at 470p.